ACAD:NASDAQ
ACADIA Pharmaceuticals Inc
$27.74
arrow_upward
+0.22%(+0.060) 1D
$27.74
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 10, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ACAD...
Open
$27.63
High
$27.86
Low
$27.36
Mkt. cap
4.78B
Avg. vol.
1.67M
Volume
37.00
P/E ratio
12.54
52-wk high
$30.96
52-wk low
$19.69
EPS
$2.21
Beta
0.86
Shares outstanding
172.31M
No. of employees
797
Open
$27.63
High
$27.86
Low
$27.36
Mkt. cap
4.78B
Avg. vol.
1.67M
Volume
37.00
P/E ratio
12.54
52-wk high
$30.96
52-wk low
$19.69
EPS
$2.21
Beta
0.86
Shares outstanding
172.31M
No. of employees
797
News stories
From web sources and news partners
https://www.dars.gov.et/
·
1 month ago
ACAD Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Stock Declines - Estimate Dispersion
Profile
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California. Wikipedia
About ACADIA Pharmaceuticals Inc
CEOCatherine Owen Adams
Employees797
Founded1993
HeadquartersSan Diego, California, United States
SectorBiotechnology
Websiteacadia.com